Balance Sheet
Cash Flow Statement
AmortizationAmortizationAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet Income
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Cash from Investing Activities (2016 - 2025)

Avricore Health has reported Cash from Investing Activities over the past 8 years, most recently at -$5524.4 for Q4 2025.

  • Quarterly Cash from Investing Activities rose 37.62% to -$5524.4 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$80549.2 through Dec 2025, up 46.66% year-over-year, with the annual reading at -$81851.3 for FY2025, 45.43% up from the prior year.
  • Cash from Investing Activities was -$5524.4 for Q4 2025 at Avricore Health, up from -$13413.7 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$917.37 in Q1 2022 and troughed at -$467863.2 in Q3 2022.
  • The 5-year median for Cash from Investing Activities is -$52294.4 (2021), against an average of -$101767.1.
  • Year-over-year, Cash from Investing Activities tumbled 18285.52% in 2023 and then skyrocketed 96.66% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$11381.2 in 2021, then plummeted by 2743.0% to -$323567.3 in 2022, then rose by 18.06% to -$265140.1 in 2023, then skyrocketed by 96.66% to -$8856.5 in 2024, then soared by 37.62% to -$5524.4 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Cash from Investing Activities are -$5524.4 (Q4 2025), -$13413.7 (Q3 2025), and -$4204.0 (Q2 2025).